Researchers continue to excited about the medication , a novel dual compound showing promising outcomes in initial trials for weight reduction . It acts by impacting two pathways : GLP-1 and GIP, https://asiyahvda195213.blogoxo.com/41158442/a-new-prospect-for-body-loss